Alicia Angelbello, PhD, is Strategic Programs Manager, Partnering & Operations at Autobahn Labs, where she supports the execution of strategic programs, partnering activities, alliance management, and cross-functional initiatives. Prior to joining Autobahn, Ali spent nearly five years at Expansion Therapeutics, where she led cross-functional preclinical drug discovery programs focused on RNA-targeted therapies for neurological and neuromuscular diseases. She subsequently served as a Scientific Program Manager at AlzLabs, leading scientific operations and coordinating multidisciplinary teams in the development of blood-based diagnostics for Alzheimer’s disease. Ali brings experience in program leadership, external collaborations and CRO management, project planning, and scientific strategy, as well as deep expertise in preclinical drug discovery. She received her PhD in Chemical and Biological Sciences from The Scripps Research Institute and her B.S. in Chemistry from Villanova University.
